Skip to main content
OpenTrials
Completed

NCT Number: NCT04210076

Mindfulness Training for Small Teams

The purpose of this study is to look at how mindfulness training may influence how the participant thinks, feels, and acts.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Miami

Coral Gables, Florida, 33146, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals who are between 18 and 65 years of age
  • Individuals who are fluent English speakers
  • Individuals who are active-duty service members
  • Men and women of all races and ethnicities

Exclusion criteria

  • Individuals who have a medical or neurological condition that might interfere with performance on the task in the study (e.g., epilepsy)
  • Individuals with a history of hospitalization for psychological/mental health issues within the last 6 months.

Treatment and study plan

MBAT-T

Behavioral

The MBAT-Team program builds on the basic 4-week, 8-hour MBAT-Soldier program. In addition to the basic program, MBAT-Team includes exercises promoting the cultivation of attention and emotion regulation in the service of effective team interactions (e.g., mindful communication and listening; monitoring and attention to the activities and emotional states of others, and additional practices to promote collective mindfulness).

MBAT-I

Behavioral

The MBAT-Individual program is based on the basic 4-week, 8-hour MBAT-Soldier curriculum.

Primary outcomes

  1. Change in Attentional Performance

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Attentional Performance as measured by the Sustained Attention Response Task (SART).This task uses a continuous performance paradigm involving button presses to frequently presented non-targets (numbers 1, 2, 4, 5, 6, 7, 8, and 9) but requires the participants to withhold their motor response to the infrequent target (number 3). Withholding responses only to infrequent targets encourages a pre-potent response and mind wandering. Real-time subjective experience of mind wandering during SART is assessed through experience-sampling probes randomly presented throughout the task.

  2. Change in Working Memory Performance

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Working Memory Performance as measured by the Working memory task with Affective Distracters. In this task, participants are presented with a memory array that they are to encode and hold in memory during a delay interval. During the delay, emotionally negative or neutral scene images are presented.

Secondary outcomes

  1. Change in Cohesion

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Cohesion as measured by 3 items adapted from a questionnaire developed by Podsakoff and MacKenzie. Scale items are rated on a scale from 1 to 5 (1 = strongly disagree, 5 = strongly agree), according to how much participants agree with each item.

  2. Change in Team Situation Monitoring

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Team Situation Monitoring is measured by 7-item subscale of the Teamwork Perception Questionnaire, which assesses individuals' shared perceptions of group-level team skills and behavior. The scale consists of a list of items that are rated on a scale from 1 to 5 (1 = strongly disagree, 5 = strongly agree), according to how much participants agree with each item.

  3. Change in Workgroup Emotional Intelligence

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Workgroup Emotional Intelligence as measured by the Workgroup Emotional Intelligence Profile, which is a 16-item measure of emotional intelligence abilities that manifest as behaviors in work teams. The scale consists of a list of items that are rated on a scale from 1 to 7 (1 = strongly disagree, 7 = strongly agree), according to how much participants agree with each item. This measure reflects an individual's judgment of their ability to monitor and manage their own emotions and the emotions of the members of their squad.

  4. Change in Team Mindfulness

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Team Mindfulness as measured by the Team Mindfulness Scale, which is a 10-item scale measuring the individual's experience of their team interactions as mindful. The total score ranges from 1 to 5, with a higher score indicating an individual's perception of the team's attitudes and experiences as marked by greater mindfulness.

  5. Change in Mindfulness

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Mindfulness as measured by the short version of the Five-Facet Mindfulness Questionnaire, which is a 15-item scale. The total score ranges from 15 to 75, with a higher score indicating greater levels of mindfulness in different aspects of one's life.

  6. Change in Decentering

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Decentering as measured by the decentering sub-scale of the Experience Questionnaire, which is an 11-item scale measuring various thoughts and experiences, and the tendency to distance from those. The total score ranges from 1 to 55, with a higher score indicating higher levels of decentering.

  7. Change in Psychological Health

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Psychological health as measured by the Patient Health Questionnaire, which is a 4-item scale measuring depression and anxiety. The total score ranges from 0 to 12, with higher scores indicating a higher level of depression and anxiety.

  8. Change in Positive Affect

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Positive affect as measured by the short version of the Positive and Negative Affect Schedule (PANAS-10), a 5-item scale measuring the frequency of experiences of positive affect. The total score ranges from 5 to 25, with a higher score indicating a higher positive mood.

  9. Change in Negative Affect

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Negative affect as measured by the short version of the Positive and Negative Affect Schedule (PANAS-10), a 5-item scale measuring the frequency of experiences of negative affect. The total score ranges from 5 to 25, with a higher score indicating a higher negative mood.

  10. Change in Perceived Stress

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Perceived Stress as measured by the short version of the Perceived Stress Scale, which is a 4-item scale measuring the degree to which situations in one's life are viewed as stressful. The total score ranges from 0 to 16, with a higher score indicating higher levels of perceived stress.

Other outcomes

  1. Change in Accuracy on Cognitive and Marksmanship Drills

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Marksmanship will be measured with drills involving synthetic rifles to interact with stimuli in an augmented reality environment. Accuracy in the drills will be scored from 0% to 100%, with a higher score indicating better performance.

  2. Change in Reaction Time on Cognitive and Marksmanship Drills

    Time frame: Baseline (testing session 1) to week 5 (testing session 2)

    Marksmanship will be measured with drills involving synthetic rifles to interact with stimuli in an augmented reality environment. Reaction time will be measured in milliseconds, with lower values indicating faster responses.

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Collaborators

  • United States Department of Defense

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Dec 24, 2019
Registry last updated
Sep 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.